Herz-Kreislauf-Kranke profitieren von ACE-Hemmer

  • r -- The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on death of cardiovascular causes, myocardial infarction, and stroke in high-risk patients. N Engl J Med 2000 (20. Januar); [Link]